Skip to main content
. Author manuscript; available in PMC: 2024 Feb 5.
Published in final edited form as: Vaccine. 2010 Dec 31;29(39):6763–6770. doi: 10.1016/j.vaccine.2010.12.055

TABLE 1.

Neutralization Titer ID50 in TNuZM-bl cells1

Group Bleed Wk MW965.26 SHIV-1157ip d3N4 MN SF162.LS Bal.26 W61D-TCLA.71
Control Pre-immune 20 21.6 20 20 20 20
2 wks post final boost 20 20 20 20 20 20
6 wks post challenge 47.2 24.6 34.4 20 20 25.4
DNA Pre-immune 20 25 20 20 20 20
2 wks post final boost 92.6 20.2 45.4 20 20 36.2
6 wks post challenge 8252.8 21.2 11127.6 879.6 87.2 642.6
DNA + RANTES Pre-immune 20 26.2 20 20 20 20
2 wks post final boost 152 21 90 23 20 36.8
6 wks post challenge 5359.2 26.8 7287.6 1242 163 2522.6